Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2012-02-22 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于控股股东股权变更的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a change in the shareholding structure of the company's controlling shareholder. It details the change in ownership percentages and the direct holding of shares by a shareholder, with no financial statements or detailed financial analysis included. The document is short (1436 characters) and focuses on ownership changes rather than financial results or management changes. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2012-02-22 Chinese
2012年第一次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, agenda, and voting results of the 2012 first extraordinary shareholders' meeting of the company. It details the legality and compliance of the meeting process and resolutions passed. It is not the actual shareholder meeting materials or voting results announcement but a legal opinion on the meeting's conduct and validity. The document length is under 5,000 characters and is a formal legal opinion, not a report or announcement of voting results. Therefore, it does not fit categories like AGM Information, Declaration of Voting Results, or Proxy Solicitation. It is best classified as a Regulatory Filing (RNS) as it is a legal compliance document related to the shareholders' meeting.
2012-02-19 Chinese
2012年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2012 first extraordinary general meeting (临时股东大会) of the company 中源协和干细胞生物工程股份公司. It includes voting results on various proposals related to termination of a private placement plan, acquisition of shares, non-public stock issuance, and related authorizations. The document contains detailed voting outcomes and procedural information about the meeting, which is typical of a Declaration of Voting Results & Voting Rights Announcements filing. It is not a full financial report, audit report, or management discussion, but a formal announcement of shareholder voting results. The document length is sufficient and contains substantive content about the meeting and voting, not just a brief notice or a report publication announcement. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements).
2012-02-19 Chinese
第七届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company 中源协和干细胞生物工程股份公司. It includes approval of the 2011 annual report, board work report, financial statements, profit distribution plan, appointment of auditors, and revisions to internal control policies. The document states that these items will be submitted to the 2011 annual shareholders meeting for approval, and the board will notify the shareholders of the meeting date separately. The document is not the annual report itself but a board meeting resolution announcement regarding the annual report and related matters. It is a formal disclosure of board decisions rather than the full report or financial statements. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board decisions and management information. The document length is short (1504 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2012-02-17 Chinese
内幕信息知情人管理制度（2012年2月）
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人管理制度' which translates to 'Insider Information Insider Management System'. It details the company's internal policies and procedures for managing insider information, including definitions, scope, registration, confidentiality, and responsibilities. It references regulatory frameworks such as the Company Law of China, Securities Law, and Shanghai Stock Exchange listing rules. The content is a governance and compliance policy document rather than a financial report, earnings release, or announcement. It does not contain financial data, earnings, or voting results. It is not a report publication announcement or a certification. Therefore, it fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2012-02-17 Chinese
2011年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Directors' Report for the Year 2011" from a company's board. It details the independent directors' attendance at board meetings, their opinions on management appointments and remuneration, their supervision of information disclosure, and their efforts to protect investor rights. The content focuses on governance and oversight activities by independent directors rather than financial results or audit opinions. The document length is short (1361 characters) and it is a report by independent directors on their duties and activities during the year. This fits best under Board/Management Information (MANG) as it relates to board activities and management oversight rather than a full annual report, audit report, or other categories. Therefore, the classification is MANG with high confidence.
2012-02-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.